… Adverse drug reaction of both erlotinib (n=37) and gefitinib (n=34) … Terminology Criteria for
Adverse Events grading system. … erlotinib and gefitinib had similar effectiveness but gefitinib …

… with more efficient management of adverse events may in part … 3 or 4 adverse events for
afatinib, gefitinib, and erlotinib were … gefitinib and erlotinib have both demonstrated efficacy for …

… to compare the effectiveness of first line TKIs; gefitinib, erlotinib, and afatinib in the treatment
of advanced stage NSCLC patients … adverse event and fatal adverse event in afatinib group …

… Although these limitations exist, our study is the largest comparing CNS efficacy between
first- … Because a prospective study comparing CNS efficacy between first- or second-generation …

… adverse events. No significant difference was observed in the incidence of adverse events
of any grade or adverse events of grade 3–4 between erlotinib and gefitinib. Numerically, …

… compare the efficacy among three first-generation EGFR-TKIs as adjuvant treatment and the
recurrence pattern in patients … had a similar detrimental effect in patients with stage IA stage …

… these three EGFR-TKIs (gefitinib, erlotinib and afatinib), have different efficacy in … adverse
effects and grade 3 gastrointestinal adverse effects than those on first-line gefitinib and erlotinib…

… incidence of these adverse events would compare with patients receiving erlotinib/gefitinib
[8, … Based on data showing limited efficacy and excessive toxicity versus the erlotinib/gefitinib …

… However, grade ≥3 adverse events, including skin toxicities, paronychia, mucositis, and …
However, afatinib remained the TKI of choice for older patients compared to erlotinib or gefitinib…

… significantly improved PFS compared with erlotinib or gefitinib (18.9 … Rates for adverse
events were lower with osimertinib than … superior efficacy to erlotinib or gefitinib in patients with …